Quidel announced completion of an all-cash deal to buy RPS Diagnostics' InflammaDry and AdenoPlus diagnostic businesses for about $14 million. The businesses include rapid, lateral flow assays designed for the detection of infectious and inflammatory eye conditions.
$14M deal to acquire Dx businesses from RPS Diagnostics finalized by Quidel
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.